Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.09.07.671934

peakScout - a user-friendly and reversible peak-to-gene translator for genomic peak calling results

Lin, A. L.·Cartailler, L. A.·Cartailler, J.-P.
View original source ↗Export metadata ↓

Abstract

SummarypeakScout is a command line and web-based bioinformatics tool designed to quickly and easily bridge the gap between genomic peak data and gene annotations, enabling researchers to understand the relationship between measurements of regulatory elements and their target genes. At its core, peakScout processes genomic peak files obtained through various means chromatin profiling and maps them to nearby genes using reference genome annotations. The workflow begins with input processing, where peak files are standardized and reference GTF files are decomposed into chromosome-specific feature collections. The core analysis modules then perform bidirectional mapping: peak-to-gene identifies which genes are potentially regulated by specific genomic regions, while gene-to-peak reveals which regulatory elements might influence particular genes of interest. Throughout this process, nearest-feature detection algorithms handle the complex spatial relationships between genomic elements, considering factors like distance constraints and feature overlaps. Finally, the results are formatted into researcher-friendly CSV and Excel outputs, providing a comprehensive view of the genomic landscape that connects regulatory elements to their potential gene targets. Availability and implementationThe web version of peakScout is available at https://vandydata.github.io/peakScout/. The command line version is available at https://github.com/vandydata/peakScout and archived on Zenodo (URL to be provided upon version 1.0 release) under the GNU Affero General Public License v3.0. Installation instructions, example datasets, and detailed usage examples are provided in the GitHub repository README file. peakScout is implemented in Python and is platform independent, but the web version is implemented in Amazon Web Services and thus uses proprietary infrastructure.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Lin, A. L., Cartailler, L. A., Cartailler, J.-P.. 2025-09-08. peakScout - a user-friendly and reversible peak-to-gene translator for genomic peak calling results. https://doi.org/10.1101/2025.09.07.671934

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗
bioRxiv2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗
bioRxiv2026

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗